Pan Y, Hao Y, Han H, et al. Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer. J Immunother Cancer 2022;10:e004913. doi: 10.1136/jitc-2022-004913

Figure 2 has been updated to resolve an error in section B.